This paper discusses how the transition to Zoom changed the evaluation of the drug court and service delivery.
While we expected to conduct in-person focus groups and interviews with the court team and participants, as well as in-person observations of team meetings and court, these were not possible from March 2020 to June 2021 (in person court resumed in July 2021). Consequently, we adapted the now-funded, ongoing evaluation plan to conduct observations, interviews, and coding via Zoom and Qualtrics. We discuss the strengths, limitations, and early lessons learned from this endeavor. We also report initial findings on how COVID-19 affected service delivery and explore the possible implications of online drug court beyond the pandemic.
Downloads
Similar Publications
- An Officer-Level Examination of the Prevalence and Correlates of Police Body-Worn Camera Activation
- Changes in transmucosal buprenorphine utilization for opioid use disorder treatment during the COVID-19 pandemic in Kentucky
- Impacts of PDMP policy changes and county opioid safety coalitions on prescribing and overdose outcomes in California 2015-2018